UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Vinva Investment Management Ltd

Vinva Investment Management Ltd reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,079 shares of the healthcare conglomerate’s stock after selling 1,018 shares during the quarter. UnitedHealth Group comprises 0.8% of Vinva Investment Management Ltd’s investment portfolio, making the stock its 20th biggest holding. Vinva Investment Management Ltd’s holdings in UnitedHealth Group were worth $19,337,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter worth $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.9 %

Shares of UNH opened at $503.61 on Wednesday. The stock’s 50-day moving average is $510.90 and its two-hundred day moving average is $548.54. The stock has a market cap of $460.66 billion, a PE ratio of 32.49, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analyst Weigh In

Several research firms have weighed in on UNH. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.